FRESENIUS MEDICAL CARE overview

Fresenius Medical Care starts the year with strong earnings growth PR Newswire BAD HOMBURG, Germany, May 7, 2024 Solid revenue 1 growth of 4% driven by both segments Care Delivery and Care Enablement Operating income 1 margin improved in both segments Care Enablement delivered strong sequential margin improvement with significant progress towards the 2025 target margin band Execution of transformation continues at pace, contributing additional FME25 savings of EUR 52 million Portfolio...

Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care PR Newswire BAD HOMBURG, Germany, March 22, 2024 Fresenius Medical Care delivers on commitments during a year of fundamental transformation Progress towards sustainability goals in key areas: patient satisfaction, diversity in management, climate target roadmap BAD HOMBURG, Germany , March 22, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of...

Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device PR Newswire BAD HOMBURG, Germany, March 19, 2024 For the first time, Fresenius Medical Care develops and utilizes "Augmented Reality" (AR) to train medical staff in Intensive Care Units (ICUs) The new training application for ICU staff combines digital learning elements with real-life training on the Fresenius Medical Care Continuous Kidney Replacement Therapy system This learning experience...

Fresenius Medical Care appoints Jörg Häring as new Management Board member responsible for Legal, Compliance and Human Resources PR Newswire BAD HOMBURG, Germany, March 13, 2024 Effective June 1 , the Legal, Compliance, and Human Resources functions will be combined in a new Management Board role Jörg Häring contributes his extensive expertise from the energy, industry, and healthcare sectors BAD HOMBURG, Germany , March 13, 2024 /PRNewswire/ -- Fresenius Medical Care , the world's leading...

Fresenius Medical Care Achieves Next Milestone in Portfolio Optimization Program, Announcing Sale of Dialysis Clinics in Brazil, Colombia, Chile, Ecuador PR Newswire BAD HOMBURG, Germany, March 5, 2024 Divestment of assets includes four separate country transactions to DaVita Inc. for USD 300 million Transactions further reduce the Company`s clinic footprint in Latin America , following the exit from Argentina at the end of 2023 Expected to close throughout 2024 Proceeds to be used to reduce...

Fresenius Medical Care delivers on commitments in a year of fundamental transformation PR Newswire BAD HOMBURG, Germany, Feb. 20, 2024 Revenue growth of 5% in 2023 driven by favorable business development Operating income 1 growth of 15% exceeding top end of outlook range, due to business growth, FME25 savings ahead of plan and contributions from the Tricare settlement Successful execution on turnaround plan resulting in significant labor productivity improvements in Care Delivery and positive...

Fresenius Medical Care Brings Industry-Leading Dialysis Therapy to Kidney Disease Patients in the U.S., demonstrating Global Leadership in Medical Device and Membrane Engineering Technologies PR Newswire BAD HOMBURG, Germany, Feb. 8, 2024 Fresenius Medical Care (FME) receives U.S. Food and Drug Administration (FDA) 510(k) clearance of the company's 5008X Hemodialysis System. This will enable Fresenius Medical Care to offer the industry-leading, high-volume hemodiafiltration (Hv-HDF) dialysis...

Fresenius Medical Care AG nominates Six Employee Representatives to the Supervisory Board PR Newswire BAD HOMBURG, Germany, Feb. 5, 2024 BAD HOMBURG, Germany , Feb. 5, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, has nominated six employee representatives as members of the company's Supervisory Board. Effective January 26 , the competent court approved the company's application for the judicial...